Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus

Shu Chen Wang, Chia Hui Lin, Tsan Teng Ou, Cheng Chin Wu, Wen Chan Tsai, Chaur Jong Hu, Hong Wen Liu, Jeng Hsien Yen

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective. To investigate the role of ligands for programmed cell death 1 (PD-L) in the pathogenesis of systemic lupus erythematosus (SLE). Methods. One hundred sixty-four patients with SLE and 160 healthy controls were enrolled in our study. The PD-L1 and PD-L2 polymorphisms were determined by polymerase chain reaction (PCR)/direct sequencing or restriction fragment length polymorphism (RFLP)-PCR. Results. The genotype distributions of PD-L2 47103 C/T polymorphisms in patients with SLE were significantly different from those of the controls (p = 0.003). The genotype frequency of PD-L2 47103 T/T, in comparison with 47103 C/C, was significantly increased in patients with SLE when compared with that of the controls (odds ratio 2.5,95% confidence interval 1.4-4.4, p = 0.001). A similar finding could also be found in the allele frequency of PD-L2 47103 T (SLE vs control, OR 1.7, 95% CI 1.3-2.4, p = 0.001). There were no significant differences in the genotype and allele frequencies of PD-L1 polymorphisms between the patients and controls. Conclusion. PD-L2 47103 T may be associated with susceptibility to SLE in Taiwan.

Original languageEnglish
Pages (from-to)721-725
Number of pages5
JournalJournal of Rheumatology
Volume34
Issue number4
Publication statusPublished - Apr 2007

Fingerprint

Systemic Lupus Erythematosus
Cell Death
Ligands
Genes
Genotype
Gene Frequency
Polymerase Chain Reaction
Taiwan
Restriction Fragment Length Polymorphisms
Odds Ratio
Confidence Intervals

Keywords

  • Programmed cell death 1
  • Programmed cell death 1 ligand
  • Programmed cell death 2 ligand
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Wang, S. C., Lin, C. H., Ou, T. T., Wu, C. C., Tsai, W. C., Hu, C. J., ... Yen, J. H. (2007). Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus. Journal of Rheumatology, 34(4), 721-725.

Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus. / Wang, Shu Chen; Lin, Chia Hui; Ou, Tsan Teng; Wu, Cheng Chin; Tsai, Wen Chan; Hu, Chaur Jong; Liu, Hong Wen; Yen, Jeng Hsien.

In: Journal of Rheumatology, Vol. 34, No. 4, 04.2007, p. 721-725.

Research output: Contribution to journalArticle

Wang, SC, Lin, CH, Ou, TT, Wu, CC, Tsai, WC, Hu, CJ, Liu, HW & Yen, JH 2007, 'Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus', Journal of Rheumatology, vol. 34, no. 4, pp. 721-725.
Wang, Shu Chen ; Lin, Chia Hui ; Ou, Tsan Teng ; Wu, Cheng Chin ; Tsai, Wen Chan ; Hu, Chaur Jong ; Liu, Hong Wen ; Yen, Jeng Hsien. / Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus. In: Journal of Rheumatology. 2007 ; Vol. 34, No. 4. pp. 721-725.
@article{0fb0adff344c45a7b62630b3ba551b64,
title = "Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus",
abstract = "Objective. To investigate the role of ligands for programmed cell death 1 (PD-L) in the pathogenesis of systemic lupus erythematosus (SLE). Methods. One hundred sixty-four patients with SLE and 160 healthy controls were enrolled in our study. The PD-L1 and PD-L2 polymorphisms were determined by polymerase chain reaction (PCR)/direct sequencing or restriction fragment length polymorphism (RFLP)-PCR. Results. The genotype distributions of PD-L2 47103 C/T polymorphisms in patients with SLE were significantly different from those of the controls (p = 0.003). The genotype frequency of PD-L2 47103 T/T, in comparison with 47103 C/C, was significantly increased in patients with SLE when compared with that of the controls (odds ratio 2.5,95{\%} confidence interval 1.4-4.4, p = 0.001). A similar finding could also be found in the allele frequency of PD-L2 47103 T (SLE vs control, OR 1.7, 95{\%} CI 1.3-2.4, p = 0.001). There were no significant differences in the genotype and allele frequencies of PD-L1 polymorphisms between the patients and controls. Conclusion. PD-L2 47103 T may be associated with susceptibility to SLE in Taiwan.",
keywords = "Programmed cell death 1, Programmed cell death 1 ligand, Programmed cell death 2 ligand, Systemic lupus erythematosus",
author = "Wang, {Shu Chen} and Lin, {Chia Hui} and Ou, {Tsan Teng} and Wu, {Cheng Chin} and Tsai, {Wen Chan} and Hu, {Chaur Jong} and Liu, {Hong Wen} and Yen, {Jeng Hsien}",
year = "2007",
month = "4",
language = "English",
volume = "34",
pages = "721--725",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "4",

}

TY - JOUR

T1 - Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus

AU - Wang, Shu Chen

AU - Lin, Chia Hui

AU - Ou, Tsan Teng

AU - Wu, Cheng Chin

AU - Tsai, Wen Chan

AU - Hu, Chaur Jong

AU - Liu, Hong Wen

AU - Yen, Jeng Hsien

PY - 2007/4

Y1 - 2007/4

N2 - Objective. To investigate the role of ligands for programmed cell death 1 (PD-L) in the pathogenesis of systemic lupus erythematosus (SLE). Methods. One hundred sixty-four patients with SLE and 160 healthy controls were enrolled in our study. The PD-L1 and PD-L2 polymorphisms were determined by polymerase chain reaction (PCR)/direct sequencing or restriction fragment length polymorphism (RFLP)-PCR. Results. The genotype distributions of PD-L2 47103 C/T polymorphisms in patients with SLE were significantly different from those of the controls (p = 0.003). The genotype frequency of PD-L2 47103 T/T, in comparison with 47103 C/C, was significantly increased in patients with SLE when compared with that of the controls (odds ratio 2.5,95% confidence interval 1.4-4.4, p = 0.001). A similar finding could also be found in the allele frequency of PD-L2 47103 T (SLE vs control, OR 1.7, 95% CI 1.3-2.4, p = 0.001). There were no significant differences in the genotype and allele frequencies of PD-L1 polymorphisms between the patients and controls. Conclusion. PD-L2 47103 T may be associated with susceptibility to SLE in Taiwan.

AB - Objective. To investigate the role of ligands for programmed cell death 1 (PD-L) in the pathogenesis of systemic lupus erythematosus (SLE). Methods. One hundred sixty-four patients with SLE and 160 healthy controls were enrolled in our study. The PD-L1 and PD-L2 polymorphisms were determined by polymerase chain reaction (PCR)/direct sequencing or restriction fragment length polymorphism (RFLP)-PCR. Results. The genotype distributions of PD-L2 47103 C/T polymorphisms in patients with SLE were significantly different from those of the controls (p = 0.003). The genotype frequency of PD-L2 47103 T/T, in comparison with 47103 C/C, was significantly increased in patients with SLE when compared with that of the controls (odds ratio 2.5,95% confidence interval 1.4-4.4, p = 0.001). A similar finding could also be found in the allele frequency of PD-L2 47103 T (SLE vs control, OR 1.7, 95% CI 1.3-2.4, p = 0.001). There were no significant differences in the genotype and allele frequencies of PD-L1 polymorphisms between the patients and controls. Conclusion. PD-L2 47103 T may be associated with susceptibility to SLE in Taiwan.

KW - Programmed cell death 1

KW - Programmed cell death 1 ligand

KW - Programmed cell death 2 ligand

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=34247382104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247382104&partnerID=8YFLogxK

M3 - Article

C2 - 17343323

AN - SCOPUS:34247382104

VL - 34

SP - 721

EP - 725

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 4

ER -